Erbium: YAG laser-mediated oligonucleotide and DNA delivery via the skin: An animal study

Woan Ruoh Lee, Shing Chuan Shen, Ching Ru Liu, Chia Lang Fang, Jun-Hung Hu, Jia You Fang

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Topical delivery of antisense oligonucleotides (ASOs) and DNA is attractive for treatment of skin disorders. However, this delivery method is limited by the low permeability of the stratum corneum (SC). The objective of this study was to enhance and optimize the skin absorption of gene-based drugs by an erbium:yttrium-aluminum-garnet (Er:YAG) laser. The animal model utilized nude mice. In the in vitro permeation study, the Er:YAG laser treatment produced a 3-30-fold increase in ASO permeation which was dependent on the laser fluence and ASO molecular mass used. The fluorescence microscopic images showed a more-significant localization of a 15-mer ASO in the epidermis and hair follicles after laser application as compared with the control. The expressions of reporter genes coding for β-galactosidase and green fluorescent protein (GFP) in skin were assessed by X-gal staining and confocal laser scanning microscopy. The SC ablation effect and photomechanical waves produced by the Er:YAG laser resulted in DNA expression being extensively distributed from the epidermis to the subcutis. The GFP expression in 1.4 J/cm2-treated skin was 160-fold higher than that in intact skin. This non-invasive, well-controlled technique of using an Er:YAG laser for gene therapy provides an efficient strategy to deliver ASOs and DNA via the skin.

Original languageEnglish
Pages (from-to)344-353
Number of pages10
JournalJournal of Controlled Release
Volume115
Issue number3
DOIs
Publication statusPublished - Oct 27 2006

Fingerprint

Erbium
Antisense Oligonucleotides
Solid-State Lasers
Oligonucleotides
Skin
Antisense DNA
DNA
Green Fluorescent Proteins
Epidermis
Cornea
Lasers
Galactosidases
Skin Absorption
Hair Follicle
Laser Therapy
Reporter Genes
Nude Mice
Confocal Microscopy
Genetic Therapy
Permeability

Keywords

  • DNA
  • Erbium:YAG laser
  • Oligonucleotide
  • Skin
  • Topical delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Erbium : YAG laser-mediated oligonucleotide and DNA delivery via the skin: An animal study. / Lee, Woan Ruoh; Shen, Shing Chuan; Liu, Ching Ru; Fang, Chia Lang; Hu, Jun-Hung; Fang, Jia You.

In: Journal of Controlled Release, Vol. 115, No. 3, 27.10.2006, p. 344-353.

Research output: Contribution to journalArticle

@article{3b9455660a024d8090eede6306afb791,
title = "Erbium: YAG laser-mediated oligonucleotide and DNA delivery via the skin: An animal study",
abstract = "Topical delivery of antisense oligonucleotides (ASOs) and DNA is attractive for treatment of skin disorders. However, this delivery method is limited by the low permeability of the stratum corneum (SC). The objective of this study was to enhance and optimize the skin absorption of gene-based drugs by an erbium:yttrium-aluminum-garnet (Er:YAG) laser. The animal model utilized nude mice. In the in vitro permeation study, the Er:YAG laser treatment produced a 3-30-fold increase in ASO permeation which was dependent on the laser fluence and ASO molecular mass used. The fluorescence microscopic images showed a more-significant localization of a 15-mer ASO in the epidermis and hair follicles after laser application as compared with the control. The expressions of reporter genes coding for β-galactosidase and green fluorescent protein (GFP) in skin were assessed by X-gal staining and confocal laser scanning microscopy. The SC ablation effect and photomechanical waves produced by the Er:YAG laser resulted in DNA expression being extensively distributed from the epidermis to the subcutis. The GFP expression in 1.4 J/cm2-treated skin was 160-fold higher than that in intact skin. This non-invasive, well-controlled technique of using an Er:YAG laser for gene therapy provides an efficient strategy to deliver ASOs and DNA via the skin.",
keywords = "DNA, Erbium:YAG laser, Oligonucleotide, Skin, Topical delivery",
author = "Lee, {Woan Ruoh} and Shen, {Shing Chuan} and Liu, {Ching Ru} and Fang, {Chia Lang} and Jun-Hung Hu and Fang, {Jia You}",
year = "2006",
month = "10",
day = "27",
doi = "10.1016/j.jconrel.2006.08.012",
language = "English",
volume = "115",
pages = "344--353",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Erbium

T2 - YAG laser-mediated oligonucleotide and DNA delivery via the skin: An animal study

AU - Lee, Woan Ruoh

AU - Shen, Shing Chuan

AU - Liu, Ching Ru

AU - Fang, Chia Lang

AU - Hu, Jun-Hung

AU - Fang, Jia You

PY - 2006/10/27

Y1 - 2006/10/27

N2 - Topical delivery of antisense oligonucleotides (ASOs) and DNA is attractive for treatment of skin disorders. However, this delivery method is limited by the low permeability of the stratum corneum (SC). The objective of this study was to enhance and optimize the skin absorption of gene-based drugs by an erbium:yttrium-aluminum-garnet (Er:YAG) laser. The animal model utilized nude mice. In the in vitro permeation study, the Er:YAG laser treatment produced a 3-30-fold increase in ASO permeation which was dependent on the laser fluence and ASO molecular mass used. The fluorescence microscopic images showed a more-significant localization of a 15-mer ASO in the epidermis and hair follicles after laser application as compared with the control. The expressions of reporter genes coding for β-galactosidase and green fluorescent protein (GFP) in skin were assessed by X-gal staining and confocal laser scanning microscopy. The SC ablation effect and photomechanical waves produced by the Er:YAG laser resulted in DNA expression being extensively distributed from the epidermis to the subcutis. The GFP expression in 1.4 J/cm2-treated skin was 160-fold higher than that in intact skin. This non-invasive, well-controlled technique of using an Er:YAG laser for gene therapy provides an efficient strategy to deliver ASOs and DNA via the skin.

AB - Topical delivery of antisense oligonucleotides (ASOs) and DNA is attractive for treatment of skin disorders. However, this delivery method is limited by the low permeability of the stratum corneum (SC). The objective of this study was to enhance and optimize the skin absorption of gene-based drugs by an erbium:yttrium-aluminum-garnet (Er:YAG) laser. The animal model utilized nude mice. In the in vitro permeation study, the Er:YAG laser treatment produced a 3-30-fold increase in ASO permeation which was dependent on the laser fluence and ASO molecular mass used. The fluorescence microscopic images showed a more-significant localization of a 15-mer ASO in the epidermis and hair follicles after laser application as compared with the control. The expressions of reporter genes coding for β-galactosidase and green fluorescent protein (GFP) in skin were assessed by X-gal staining and confocal laser scanning microscopy. The SC ablation effect and photomechanical waves produced by the Er:YAG laser resulted in DNA expression being extensively distributed from the epidermis to the subcutis. The GFP expression in 1.4 J/cm2-treated skin was 160-fold higher than that in intact skin. This non-invasive, well-controlled technique of using an Er:YAG laser for gene therapy provides an efficient strategy to deliver ASOs and DNA via the skin.

KW - DNA

KW - Erbium:YAG laser

KW - Oligonucleotide

KW - Skin

KW - Topical delivery

UR - http://www.scopus.com/inward/record.url?scp=33751021090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751021090&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2006.08.012

DO - 10.1016/j.jconrel.2006.08.012

M3 - Article

C2 - 17005286

AN - SCOPUS:33751021090

VL - 115

SP - 344

EP - 353

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -